Putnam Investments LLC Fennec Pharmaceuticals Inc. Transaction History

Putnam Investments LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 14, 2019	SELL	$3.3 - $5.09 $864,708 - $1.33 Million	-262,033 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$7.84 - $10.83 $10,976 - $15,162	-1,400 Reduced 0.53%	262,033 $2.15 Million
Q1 2018 May 15, 2018	BUY	$8.26 - $12.1 $1.2 Million - $1.76 Million	145,788 Added 123.92%	263,433 $3.19 Million
Q4 2017 Feb 14, 2018	BUY	$8.9 - $12.35 $1.05 Million - $1.45 Million	117,645	117,645 $1.17 Million

14.9M

10K

83.8K

Ticker FENC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 26,067,300
Market Cap $157M
Description
Fennec Pharmaceuticals Inc. operates as a biopharmaceutical company. Its product candidate in the clinical stage of development is PEDMARK, a formulation of sodium thiosulfate for the prevention of platinum-induced ototoxicity in pediatric cancer patients. The company was formerly known as Adherex Technologies Inc. and changed its name to Fennec...

Get notified when there are updates to the investment portfolio of Putnam Investments LLC, based on Form 13F filings with the SEC.

Stay updated on Putnam Investments LLC with notifications on news.